Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial)

American Journal of Cardiology

Volumn 110, Issue 11, 2012, Pages 1561-1567

  Tandjung, Kenneth ^a,b   Van Houwelingen, K Gert ^a,b   Jansen, Hanneke ^a,b,c   Basalus, Mounir W Z ^a,b   Sen, Hanim ^a,b   Löwik, Marije M ^a,b   Stoel, Martin G ^a,b   Louwerenburg, J W ^a,b   De Man, Frits H A F ^a,b   Linssen, Gerard C M ^d   Nijhuis, Rogier ^d   Nienhuis, Mark B ^a   Van Der Palen, Job ^b,e   Stolk, Ronald P ^c   Von Birgelen, Clemens ^a,b,e  

^a Thoraxcentrum ^*  (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d TWENTEBORG HOSPITAL   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PERIPROCEDURAL MYOCARDIAL INFARCTION; PRIORITY JOURNAL;

AGED; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84869079421     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.07.019     Document Type: Article

References (29)

1. M.P. Bonaca, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.T. Ruff, E.M. Antman, D.A. Morrow American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Circulation 125 2012 577 583
2. M.B. Nienhuis, J.P. Ottervanger, H.J. Bilo, B.D. Dikkeschei, F. Zijlstra Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis Catheter Cardiovasc Interv 71 2008 318 324
3. C. Berry, S. Noble, J.C. Grégoire, R. Ibrahim, S. Levesquie, M.A. Lavoie, P.L. L'Allier, J.C. Tardif Glycaemic status influences the nature and severity of coronary artery disease Diabetologia 53 2010 652 658
4. S. Bansilal, M.E. Farkouh, V. Fuster Role of insulin resistance and hyperglycemia in the development of atherosclerosis Am J Cardiol 99 suppl 2007 6B 14B
5. L.O. Jensen, P. Thayssen, G.S. Mintz, R. Egede, M. Maeng, A. Junker, A. Galloee, E.H. Christiansen, K.E. Pedersen, H.S. Hansen, K.N. Hansen Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus Am J Cardiol 101 2008 590 595
6. C. von Birgelen, M.W. Basalus, K. Tandjung, K.G. van Houwelingen, M.G. Stoel, J.H. Louwerenburg, G.C. Linssen, S.A. Saïd, M.A. Kleijne, H. Sen, M.M. Löwik, J. van der Palen, P.M. Verhorst, F.H. de Man A randomized controlled trial in second-generation zotarolimus-eluting resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial J Am Coll Cardiol 59 2012 1350 1361
7. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 35 suppl 1 2012 S64 S71
8. P. Vranckx, D.E. Cutlip, R. Mehran, P.P. Kint, S. Silber, S. Windecker, P.W. Serruys Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. A.S. Kini, P. Lee, J.D. Marmur, A. Agarwal, M.E. Duffy, M.C. Kim, S.K. Sharma Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality Am J Cardiol 93 2004 18 23
11. J.B. Lindsey, K.F. Kennedy, J.M. Stolker, I.C. Gilchrist, D. Mukherjee, S.P. Marso, M.J. Pencina, N.S. Kleiman, D.J. Cohen Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry Circ Cardiovasc Interv 4 2011 474 480
12. J. Herrmann, C. Von Birgelen, M. Haude, L. Volbracht, N. Malyar, H. Eggebrecht, T.F. Konorza, D. Baumgart, R. Erbel Prognostic implication of cardiac troponin T increase following stent implantation Heart 87 2002 549 553
13. A.J. Lansky, G.W. Stone Periprocedural myocardial infarction: prevalence, prognosis, and prevention Circ Cardiovasc Interv 3 2010 602 610
14. K. Tandjung, M.W. Basalus, E. Muurman, H.W. Louwerenburg, K.G. van Houwelingen, M.G. Stoel, F.H. de Man, H. Jansen, J. Huisman, G.C. Linssen, H.T. Droste, M.B. Nienhuis, C. von Birgelen Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents Catheter Cardiovasc Interv 2011 10.1002/ccd.23334 [Epub ahead of print]
15. I. Akin, A. Bufe, S. Schneider, H. Reinecke, L. Eckardt, G. Richardt, D. Burska, J. Senges, K.H. Kuck, C.A. Nienaber Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry Clin Res Cardiol 99 2010 393 400
16. G.W. Stone, E. Kedhi, D.J. Kereiakes, H. Parise, M. Fahy, P.W. Serruys, P.C. Smits Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus Circulation 124 2011 893 900
17. M. Sabate, P. Jimenez-Quevedo, D.J. Angiolillo, J.A. Gomez-Hospital, F. Alfonso, R. Hernandez-Antolin, J. Goicolea, C. Banuelos, J. Escaned, R. Moreno, C. Fernandez, F. Fernandez-Aviles, C. Macaya DIABETES Investigators Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial Circulation 112 2005 2175 2183
18. E. Selvin, M.W. Steffes, H. Zhu, K. Matsushita, L. Wagenknecht, J. Pankow, J. Coresh, F.L. Brancati Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
19. J.R. Timmer, M. Hoekstra, M.W. Nijsten, I.C. van der Horst, J.P. Ottervanger, R.J. Slingerland, J.H. Dambrink, H.J. Bilo, F. Zijlstra, A.W. van 't Hof Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention Circulation 124 2011 704 711
20. M. Zheng, S.Y. Choi, S.J. Tahk, H.S. Lim, H.M. Yang, B.J. Choi, M.H. Yoon, J.S. Park, G.S. Hwang, J.H. Shin The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome: a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis JACC Cardiovasc Interv 4 2011 503 510
21. D. Böse, C. von Birgelen, X.Y. Zhou, A. Schmermund, S. Philipp, S. Sack, T. Konorza, S. Möhlenkamp, K. Leineweber, P. Kleinbongard, W. Wijns, G. Heusch, R. Erbel Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions Basic Res Cardiol 103 2008 587 597
22. P. Zimmet, K.G. Alberti, J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787
23. H.C. Gerstein, M.E. Miller, S. Genuth, F. Ismail-Beigi, J.B. Buse, D.C. Goff Jr, J.L. Probstfield, W.C. Cushman, H.N. Ginsberg, J.T. Bigger, R.H. Grimm Jr, R.P. Byington, Y.D. Rosenberg, W.T. Friedewald ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
24. J.R. Timmer, T. Svilaas, J.P. Ottervanger, J.P. Henriques, J.H. Dambrink, S.A. van den Broek, I.C. van der Horst, F. Zijlstra Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II J Am Coll Cardiol 47 2006 1730 1731
25. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565
26. M. Cohen, J.J. Ferguson Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy? Curr Opin Cardiol 24 2009 88 94
27. G. Patti, V. Pasceri, L. D'Antonio, A. D'Ambrosio, M. Macri, G. Dicuonzo, G. Colonna, A. Montinaro, G. Di Sciascio Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage during Angioplasty-Bivalirudin vs Heparin Study) Am J Cardiol 2012;110:478-484
28. F. Mangiacapra, G. Patti, A. Peace, L. Gatto, V. Vizzi, E. Ricottini, A. D'Ambrosio, O. Muller, E. Barbato, G. Di Sciascio Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention Am J Cardiol 106 2010 619 623
29. K. Tandjung, M.W. Basalus, H. Sen, G.A. Jessurun, P.W. Danse, M. Stoel, G.C. Linssen, A. Derks, T.T. van Loenhout, M.B. Nienhuis, R.W. Hautvast, C. von Birgelen DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): rationale and study design of a randomized multicenter trial in a Dutch all-comers population Am Heart J 163 2012 557 562